Business

Molecular Imaging Market will Explore Robust Size & Growth During 2018-2026

Molecular Imaging Market
Molecular Imaging Market

Molecular imaging is a technique used to study cellular and molecular processes in order to detect and diagnose complex molecular mechanisms, molecular changes, and gene expression present in the course of the disease. Molecular imaging includes the field of nuclear medicine, which use traces of radioactive materials (radiopharmaceuticals) to diagnose and treat disease. Molecular imaging provide information that is unreachable with other imaging technologies or that would require more invasive procedures such as surgery or biopsy. Moreover, it identify disease in its initial stages and determine the exact location of a tumor, often before symptoms occur or abnormalities can be detected with other diagnostic tests.

Get Access on Research Analysis and Growth Strategy

Molecular Imaging Market – Competitive Landscape

Key players operating in the global molecular imaging market include Carestream Health, Fujifilm Holdings Corporation, GE Healthcare, Hitachi Ltd, Hologic, Inc., Siemens AG, Philips Healthcare, Samsung Medison, Shimadzu Corporation, and Toshiba Medical Systems Corporation. Several players operating in the medical imaging devices market are focusing on improving the image quality, in order to cater to unmet medical imaging needs.

The global molecular imaging market was valued at US$ 3.8 billion in 2017, and is expected to witness a CAGR of 8.1% over the forecast period (2018 – 2026).

Market Dynamics

Increasing prevalence of various chronic diseases such as cancer and other genetic disorders are propelling demand for early disease diagnosis eventually driving the medical imaging market growth. According to the Centers for Disease Control and Prevention (CDC), February 2018 data, in the U.S., around 22,000 men and 9,000 women suffer from liver cancer, and around 16,000 men and 8,000 women die from liver cancer annually. Molecular imaging has become part of standard care for many types of cancer. The use of imaging techniques in early cancer detection, treatment response, and new therapy development is steadily growing and has already significantly impacted on clinical management of cancer.

Increasing incidence of cancer, cardiovascular, and neurological diseases are expected to drive the molecular imaging market growth

Increasing incidence of various diseases such as cardiovascular, cancer, inflammatory, and neurological diseases are propelling demand for molecular imaging and is expected to drive the molecular imaging market growth during the forecast period. These diseases are becoming increasingly prevalent with rising percentage of geriatric population worldwide. According to the American Heart Association 2015 data, in the U.S., around 2 million people die due to cancer and cardiovascular disease annually.

Molecular Imaging Market – Regional Insights

On the basis of region, the global molecular imaging market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America molecular imaging market is expected to foresee major revenue share, owing to well established healthcare infrastructure that offers all the molecular imaging modalities in various parts of the region. Moreover, increasing awareness among people about health coupled with prevalence of various diseases including cardiovascular, cancer, brain disorders is propelling demand for molecular imaging in the region.

Detailed Segmentation:

  • Global Molecular Imaging Market, By Technology:
    • Gamma Camera
    • Single Photon Emission Computed Tomography (SPECT)
    • Positron Emission Tomography (PET)
    • Magnetic Resonance Spectroscopy
    • Optical Imaging
    • Molecular Ultrasound Imaging

To Avail Discount on This Report @ https://www.coherentmarketinsights.com/insight/request-discount/2191